Corradini, Stefanie http://orcid.org/0000-0001-8709-7252
Niyazi, Maximilian
Verellen, Dirk
Valentini, Vincenzo
Walsh, Seán
Grosu, Anca-L.
Lauber, Kirsten
Giaccia, Amato
Unger, Kristian
Debus, Jürgen
Pieters, Bradley R.
Guckenberger, Matthias
Senan, Suresh
Budach, Wilfried
Rad, Roland
Mayerle, Julia
Belka, Claus
Article History
Received: 27 October 2020
Accepted: 28 January 2021
First Online: 4 February 2021
Ethics Approval and Consent to Participate
: Not applicable.
: Not applicable.
: CB, SC and MN received research grants from Elekta, Viewray and Brainlab. DV has an on going collaboration with SunNuclear Inc, Sordina IORT Technologies and RaySearch. SW holds a leadership position and shares in the MedTech company OncoRadiomics SA. BRP received a research grant from Elekta. SS has received departmental research grants from Varian Medical Systems, ViewRay Inc. and AstraZeneca, and personal fees from AstraZeneca, Celgene and MSD. MG received advisory board and honoraria from AstraZeneca and research support from AstraZeneca, ViewRay and Varian. JD reports grants from Viewray Inc, CRI The Clinical Research Institute GmbH, Accuray International Sari, RaySearch Laboratories AB, Vision RT Limited, Merck Serono GmbH, Astellas Pharma GmbH, Astra Zeneca GmbH, Siemens Healthcare GmbH, Solution Akademie GmbH, Egomed PLC Surrey Research Park, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH&CoKG, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix S.A outside the submitted work. VV has received departmental research grants from Varian Medical Systems, ViewRay Inc., Elekta, Merck-Serono, Roche. The other authors declare that they have no competing interests.